UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054969
Receipt number R000062777
Scientific Title A Randomized, Double-Blind, Parallel Group Study on the Effect of Continuous Consumption of Nutritionally Balanced "Bento" on Psychosomatic Disorders
Date of disclosure of the study information 2024/07/16
Last modified on 2026/01/16 17:17:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Randomized, Double-Blind, Parallel Group Study on the Effect of Continuous Consumption of Nutritionally Balanced "Bento" on Psychosomatic Disorders

Acronym

A Randomized, Double-Blind, Parallel Group Study on the Effect of Continuous Consumption of Nutritionally Balanced "Bento" on Psychosomatic Disorders

Scientific Title

A Randomized, Double-Blind, Parallel Group Study on the Effect of Continuous Consumption of Nutritionally Balanced "Bento" on Psychosomatic Disorders

Scientific Title:Acronym

A Randomized, Double-Blind, Parallel Group Study on the Effect of Continuous Consumption of Nutritionally Balanced "Bento" on Psychosomatic Disorders

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effects on psychosomatic disorders of continuous consumption of two nutritionally balanced meals ("Bento") for 12 weeks in a randomized, double-blind, parallel-group study.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

GHQ60

Key secondary outcomes

SF-12, physical condition questionnaire, skin test, sleep-wake rhythm, intestinal microflora analysis, capillary examination, body composition, vital signs, blood tests, urine test, BDHQ, Questionnaire on food consciousness and food behavior


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

low-salt meal

Interventions/Control_2

low-salt Japanese meal

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

30 years-old >

Gender

Male and Female

Key inclusion criteria

1. Subjects with informed consent for the study participation.
2. Japanese male and female students between the ages of 18 and 30
3. Those with relatively low adherence score for the food guide

Key exclusion criteria

1. those who are under medical treatment, medication, or lifestyle guidance by a physician for schizophrenia, depression, mania, neurological disorders, sleep disorders, or chronic fatigue syndrome
2. who are using metal medical devices implanted in the body (pacemakers, implantable defibrillators, artificial bone heads, plates, etc.)
3. who are receiving nutritional guidance at a medical institution
4. who are undergoing treatment or taking medication for liver disease, renal disease, gastrointestinal disease, or lifestyle-related diseases (hypertension, hyperglycemia, hyperuricemia, cardiac disease, high cholesterol, etc.)
5. who cannot continue to consume the test food for reasons such as the possibility of showing allergic symptoms
6. who is planning to make a major lifestyle change during the intake period of the test food
7. who are participating in other clinical trials, observational studies, clinical trials, or home-use tests between 4 weeks prior to the start and the end of the intake of the test food
8. who are otherwise deemed ineligible by the Principal Investigator.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Jun
Middle name
Last name Nishihira

Organization

Hokkaido Information University

Division name

Department of Medical Management and Informatics

Zip code

069-8585

Address

59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan

TEL

011-385-4430

Email

hisc-acad.res@s.do-johodai.ac.jp


Public contact

Name of contact person

1st name Jun
Middle name
Last name Nishihira

Organization

Hokkaido Information University

Division name

Health Information Science Center

Zip code

069-8585

Address

59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan

TEL

011-385-4430

Homepage URL


Email

hisc-acad.res@s.do-johodai.ac.jp


Sponsor or person

Institute

Hokkaido Information University

Institute

Department

Personal name



Funding Source

Organization

National Agriculture and Food Research Organization, bio-oriented technology Research Advancement Institution

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

University of Tsukuba
National Agriculture and Food Research Organization
National Institute of Advanced Industrial Science and Technology
KOSE Corporation

Name of secondary funder(s)



IRB Contact (For public release)

Organization

The ethics committee of Hokkaido Information University

Address

59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan

Tel

011-385-4411

Email

soumu@do-johodai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道情報大学(北海道)、筑波大学(茨城県)


Other administrative information

Date of disclosure of the study information

2024 Year 07 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 04 Month 25 Day

Date of IRB

2024 Year 04 Month 25 Day

Anticipated trial start date

2024 Year 07 Month 16 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 07 Month 15 Day

Last modified on

2026 Year 01 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062777